Home Table of Contents

 

HYPERBARIC OXYGEN

Laurance Johnston, Ph.D.

Sponsor: Institute of Spinal Cord Injury, Iceland

 

 

HBO & Acute Spinal Cord Injury

bullet

Dr. John Yeo (Australia)

bullet

Dr. Richard Jones (Australia)

bullet

Dr. Francis Gamache (USA)

bullet

Dr. M.P. Elinskii (Russia)

bullet

Dr. S. Asamato (Japan)

HBO & Chronic Spinal Cord Injury

HBO & Stem-Cell Mobilization

Hyperbaric oxygen therapy (HBO) is most commonly used to treat decompression sickness or the bends in divers who undergo rapid decompression. Patients are placed in chambers pressurized at 2-3 atmospheres containing up to 100% oxygen (compared to 21% in the air we breathe). This pressure allows the bubbles resulting from rapid decompression to be reabsorbed.

Evidence from animal and human studies suggests that HBO is beneficial for treating a variety of neurological disorders in which blood-flow-related oxygenation may be compromised (i.e., ischemia), including stroke, head injury, and acute and perhaps chronic SCI. The therapeutic premise is that HBO will force oxygen into oxygen-deprived CNS tissue resulting from injury. Dr. Wise Young (NJ, USA) has reviewed HBO therapy, including potential SCI applications (http://carecure.rutgers.edu/spinewire/articles/HBOT2001.htm). HBO has also been used to accelerate healing in SCI-associated pressure sores.

HBO & Acute Spinal Cord Injury

1) In 1978, Dr. John Yeo and colleagues (Australia) reported on the HBO treatment of 10 patients with acute SCI (Med J Aust 2(12), 1978). Eight and two patients had quadriplegia and paraplegia, respectively, and three had complete injuries. HBO treatment, consisting of two 90-minute, 2.5-atmospheres sessions, commenced within 14 hours of injury. Results suggested that recovery of motor power in five patients was more rapid and greater than would be expected from routine care.

In 1984, Yeo indicated that he had cumulatively treated 45 acutely injured patients with HBO (Central Nervous System Trauma 1(2), 1984), of whom results were reported for 27 with upper motor neuron lesions. Of the 27, 78% and 22% had cervical and thoracic injuries, respectively, and average age was 32. Patients received up to three 90-minute, 2.5-atmospheric pressurizations starting 5-14 hours after injury and were compared to 63 conventionally treated patients using the Frankel assessment scale, the predecessor to today’s commonly used ASIA scale.

Although 15 of the 27 patients had useful functional recovery, overall no statistical difference was demonstrated between treated and control patients. Yeo suggested, however, “the trend indicates that the patient with an incomplete spinal cord injury may experience additional functional recovery if treated with HBO… within hours of injury.”

2) In 1978, Dr. Richard Jones et al (Sydney, Australia) reported the results of treating nine patients with HBO within 12 hours of injury (Med J Aust 2(12), 1978). Each patient had two 120-minute, 2.5-atmospheric sessions (equivalent to a depth of 45-feet sea water) separated by an hour of normal pressure breathing. Of the treated patients, several had functional or neurological improvement.

3) In 1980, Dr. Francis Gamache and colleagues (NY, USA) presented the preliminary findings of treating 25 patients with HBO starting about 7.5 hours after injury (Surgical Neurology. 15(2), 1981). Twenty-three were male; 19 and three had cervical and thoracic injuries, respectively; and age averaged 24. Patients were treated for 90-120 minutes at 2.0-2.5 atmospheric pressure at intervals ranging initially from every two hours to twice daily. Treatment was discontinued when improvement reached a plateau. Patients were periodically evaluated for at least six months. The investigators concluded that HBO accelerated recovery, though final outcomes were comparable to those patients receiving conventional care.

4) Dr. M.P. Elinskii and colleagues (Russia) concluded that 2.8-atmospheric-pressure HBO therapy reduced neurological symptoms in patients with various spinal cord lesions (Zh Neropatol Psikhiatry Im  S S Korsakova 84(5), 1984).

5) Dr. S. Asamato et al (Tokyo, Japan) retrospectively compared 34 patients with cervical, hyperextension injuries who had and had not been treated with HBO therapy (Spinal Cord, 38(9), 2000). In HBO-treated patients, improvement ranged from 100% to 27.3% with a mean of 75.2%, whereby in the non-HBO treated group, these values were 100%, 25%, and 65.1%, respectively. The investigators concluded that the data “indicated effectiveness in acute traumatic cervical injury.”

HBO & Chronic Spinal Cord Injury

Various anecdotal reports indicate potential benefits may accrue for individuals with chronic SCI. For example, an Australian HBO program has reported functional improvement in several patients with chronic SCI (www.spinalrehab.com.au/disorders/SpinalCordInjury.htm). In one case, a 39-year old male had sustained C6-7 injury from an auto accident and further developed a C6-T1 syringomyelia cyst. Several years after injury, he commenced daily HBO therapy and reported as a result the return of sensation in legs down to his toes, stomach, and back, as well as the return of knee reflexes.  

The second case involved a 20-year-old female who had sustained a C5-6 injury from an auto accident. Before commencing HBO therapy, her improvement had been minimal. In addition to HBO treatment, she also received “assertive” physical therapy and electro-acupuncture, both of which have been shown to promote functional recovery. In a diary, she documented the incremental improvements she accrued over the course of 70 HBO pressurizations, which cumulatively were considerable, including improved bowel-and-bladder and respiratory function, circulation, pressure-sore healing, and sensation and motor control in extremities.

HBO & Stem-Cell Mobilization

Numerous animal studies suggest that HBO influences the expression of stem cells, including 1) promoting differentiation and proliferation into neurons, 2) enhancing migration to areas of injury, 3) suppressing stem-cell apoptosis, a form of programmed cell death, and 4) inducing stem-cell growth factors. In humans, Dr. Stephen Thom and colleagues (USA) have shown that HBO therapy stimulates the bone-marrow production of stem cells through a mechanism dependent on nitric oxide, a chemical that plays a key role in the spinal cord injury process. Specifically, the number of stem cells doubled in the circulation of humans after a single two-hour, two-atmosphere HBO session, and after 20 treatments, increased eight-fold.

TOP